AidsmapAn experimental vaccine regimen tested in a large trial in southern Africa did not protect young women from acquiring HIV, adding to a long string of HIV vaccine disappointments, Dr Glenda Gray of the South African Medical Research Council said last week at the Conference on Retroviruses and Opportunistic Infections (CROI 2022).
But researchers are continuing to analyse data from the trial in the hope of gleaning more information that could aid the ongoing pursuit of a vaccine to prevent HIV. In the meantime, biomedical interventions to reduce the impact of HIV among women in Africa remain urgently needed, Gray emphasised.
Read the full story at Aidsmap.
All Aidsmap reports from CROI 2022.
Source : Aidsmap
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.